Clinical trial Recruiting at 1 site Observational Ages 1 Year to 17

Pediatric Cardiac Oxygenation Monitoring During Open-Heart Surgery

Official title: Spectroscopic Assessment of Myocardial Oxygenation Changes in Pediatric Heart Surgery

Run by Spectrocor · NCT07785141 · Data updated 2026-11-12

This study tests whether the SpectroCor Tissue Oxygenation Monitor and its Sensor can track heart tissue oxygen levels in children undergoing open-heart surgery.

More Myocardial Ischemia trials

Quick facts

Study typeObservational
Ages1 Year to 17 Years
SexAll
Enrollment30 (estimated)
SponsorSpectrocor
Industry-sponsored
Locations1 site (Helsinki, Uusimaa)
StatusRecruiting
StartedSeptember 17, 2026
Main results expectedDecember 31, 2027
Study endsFebruary 28, 2029
Registry record updatedSeptember 28, 2026
Trial IDNCT07785141 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children under 18 planned for elective open-heart surgery, with informed consent from parent/guardian.

Probably not a fit

Patients with consent limitations or those not experiencing meaningful intraoperative oxygenation changes may not derive direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this single-center observational study, up to 30 pediatric patients under 18 undergoing elective open-heart surgery will be monitored with the SpectroCor system to observe tissue oxygenation during the procedure. The study aims to determine if the monitor’s readings align with perioperative changes in myocardial perfusion and other clinical parameters, and to assess safety and usability. No control group is included, and real-world clinical practice is used to reflect routine use. Age categories follow the pediatric framework to account for developmental differences.

Why it matters

Potential benefit: If successful, the monitoring approach could help clinicians see real-time tissue oxygenation changes during surgery, potentially guiding intraoperative decisions.

How similar studies have gone: Previous device-based tissue oxygenation monitoring in pediatric settings has shown potential but remains exploratory for this application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Scheduled for open-heart surgery.
* Age \<18
* Signed informed consent

Exclusion Criteria:

• Inability to provide informed consent

Where it's running

  • HUS New Childrens Hospital
    Helsinki, Uusimaa, Finland
    Recruiting

Study contacts

  • Principal investigator: Henri Haapanen, PhD — Helsinki University Hospital (HUS)
  • Study coordinator: Kalle Kotilahti
  • Email: kalle@spectrocor.com
  • Phone: +358449016550

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.